Lixisenatide shows benefits comparable to exenatide in diabetes

06/6/2013 | PhysiciansBriefing.com

Once-daily lixisenatide was as effective as twice-daily exenatide in improving A1C and fasting plasma glucose levels in adult type 2 diabetes patients who showed poor response to metformin, according to a study in Diabetes Care. Researchers also noted lower incidence of symptomatic hypoglycemia and gastrointestinal events among lixisenatide-treated patients than in those who took exenatide. However, the lixisenatide group had less weight loss compared with the exenatide group, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC